ABOUT JTME
Journal of Tumor Microenvironment (JTME) is an international, open access, peer reviewed journal dedicated to advancing the understanding of tumor microenvironment biology and highlighting groundbreaking cancer therapies. The journal is published biannually online by Molecule Publishing House. Journal of Tumor Microenvironment (JTME) serves as a platform for researchers, clinicians, and scientists to showcase their research related to the biological mechanisms of tumor progression, metastasis, and drug resistance. With a special emphasis on therapeutic advances, the journal bridges the gap between basic science discoveries and translational clinical applications, fostering collaboration and knowledge exchange among experts in the field.
Journal of Tumor Microenvironment (JTME) publishes original research articles, reviews, mini reviews, perspective articles, opinion, letters to the editor, short communications and editorials. The journal aims to maintain a balance between basic research and its clinical implications to facilitate the translation of fundamental discoveries into practical applications.
Scope
The scope of Journal of Tumor Microenvironment (JTME) encompasses a wide range of topics pertaining to the tumor microenvironment, fostering interdisciplinary collaboration between experts from diverse fields such as cancer biology, immunology, genetics, pharmacology, pathology, bioinformatics, and more. Key areas of focus include, but are not limited to:
֎ Studies exploring the complex role of stromal cells, immune cells, extracellular matrix, blood vessels, and signaling molecules within the tumor microenvironment and their influence on cancer behavior.
֎ Investigating the molecular mechanisms underlying cancer cell dissemination, migration and metastasis.
֎ Highlighting innovative diagnostic and therapeutic approaches, including immunotherapies, targeted therapies, and personalized medicine, used in cancer diagnosis and treatment.
֎ Presenting advancements in preclinical tumor models that recapitulate the complexity of the tumor microenvironment, enabling the evaluation of novel therapeutic interventions.
֎ Studying the development of resistance to chemotherapy, immunotherapy, and targeted therapies within the tumor microenvironment, and identifying novel therapeutic strategies to overcome resistance mechanisms.
֎ Identifying and validating new biomarkers and prognostic indicators associated with tumor microenvironment characteristics, prognosis, and response to therapies, that can guide personalized cancer treatment strategies.
֎ Rigorous preclinical and clinical trials investigating the safety and efficacy of new cancer therapies.
Aims
Journal of Tumor Microenvironment (JTME) aims to:
֎ Promote the advancement of cancer therapies by providing a platform for the dissemination of high-quality research and discoveries in the field of tumor microenvironment and its relevance to new treatments.
֎ Act as a catalyst for innovative research, promoting the development of novel therapeutic approaches and diagnostic tools for cancer based on the understanding of tumor microenvironment biology.
֎ Support and publish rigorous preclinical and clinical studies evaluating the safety and efficacy of new cancer therapies. By providing a platform for well-designed and well-executed preclinical and clinical studies, the journal contributes to evidence-based practice and the development of new cancer therapeutic interventions.
֎ Promote global accessibility to its content by adopting an open access publication model. The Journal seeks to foster collaboration and knowledge exchange among researchers, healthcare professionals, and experts from various disciplines, thus promoting the exchange of ideas and expertise and creating a multidisciplinary community dedicated to advancing cancer therapies.
֎ Emphasize translational research by bridging the gap between fundamental discoveries and their application in clinical settings.
Ultimately, the overarching aim of the Journal of Tumor Microenvironment (JTME) is to have a positive impact on cancer patients’ lives. By disseminating groundbreaking research and facilitating the development of new and more effective cancer therapies, the journal strives to contribute to improved patient outcomes and an overall reduction in the global burden of cancer.
